Patients with heart failure with preserved ejection fraction (HFpEF)
This review highlights the growing global burden of HFpEF and the importance of understanding its diverse clinical phenotypes and modifiable risk factors.
Heart failure (HF) with preserved ejection (HFpEF) constitutes a large and growing proportion of patients with HF around the world, and is now responsible for more than half of all HF cases in ageing societies. While classically described as a condition of elderly, hypertensive women, recent studies suggest heterogeneity in clinical phenotypes involving differential characteristics and pathophysiological mechanisms. Despite a paucity of disease-modifying therapy for HFpEF, an understanding of phenotypic similarities and differences among patients with HFpEF around the world provides the foundation to recognise the clinical condition for early treatment, as well as to identify modifiable risk factors for preventive intervention. This review summarises the epidemiology of HFpEF, its common clinical features and risk factors, as well as differences by age, comorbidities, race/ethnicity and geography.
Building similarity graph...
Analyzing shared references across papers
Loading...
K. Teramoto
Jikei University School of Medicine
Tiew‐Hwa Katherine Teng
Heart Failure & Transplant
Chanchal Chandramouli
Heart Failure & Transplant
SHILAP Revista de lepidopterología
Cardiac failure review
National University of Singapore
The University of Western Australia
University Medical Center Groningen
Building similarity graph...
Analyzing shared references across papers
Loading...
Teramoto et al. (Thu,) studied this question.
synapsesocial.com/papers/69da290eb48bb130d4684811 — DOI: https://doi.org/10.15420/cfr.2022.06